News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

No Tears for Johnson & Johnson (JNJ), Still Remarkable



7/18/2012 7:16:47 AM

After the earnings for Johnson & Johnson (JNJ) were released this morning, I was getting some of my dry powder ready to pounce. The pre-market had the shares down nearly 1.5%, as sales of $16.5 billion was down about 1% from last year. Not only that, sales were down in the U.S., as well as the rest of the world in total. In addition, there were currency issues that had a negative impact as well. As we always try to do with dividend investing, we were ready and able to gobble up some shares on the dip, which we thought would be dramatic. ?

Read at Seeking Alpha
Read at MorningStar.com
Read at Boston Globe
Read at Philadelphia Inquirer
Read at nj.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES